Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocio Montejano

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Medical Mycology|December 19, 2017
In vitro activity of isavuconazole against fluconazole-resistant isolates of Histoplasma capsulatumAndrej Spec, Patricia Connolly, Rocio Montejano, et al.
Expert Opinion on Drug Safety|December 5, 2017
A safety evaluation of raltegravir for the treatment of HIVRosa de Miguel, Rocio Montejano, Natalia Stella-Ascariz, et al.
Current HIV/AIDS Reports|January 22, 2018
New Strategies of ARV: the Road to SimplificationRosa de Miguel Buckley, Rocio Montejano, Natalia Stella-Ascariz, et al.
Expert Opinion on Drug Safety|February 9, 2021
Risks and benefits of reducing the number of drugs to treat HIV-1 infectionJulen Cadiñanos, Rocio Montejano, Rosa de Miguel Buckley, et al.
Open Forum Infectious Diseases|March 24, 2016
Long-Term Control of Human Immunodeficiency Virus-1 Replication Despite Extensive Resistance to Current Antiretroviral Regimens: Clonal Analysis of Resistance Mutations in Proviral Deoxyribonucleic AcidNatalia Stella-Ascariz, Rocio Montejano, María Martin-Vicente, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2023
The Current Mismatch Between COVID-19 Clinical Trial Design and the Evolving Profile of Hospitalized Patients: A Retrospective Cohort AnalysisRocio Montejano, Alfredo Soler-Carracedo, Alberto M Borobia, et al.
HIV Medicine|May 6, 2026
Preference for different PrEP formulations: A cross-sectional study in a PrEP cohort in SpainAlfredo Soler-Carracedo, Allison R Webel, Luis Ramos-Ruperto, et al.
Open Forum Infectious Diseases|January 12, 2018
Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus StudySarah L Pett, Ken M Kunisaki, Deborah Wentworth, et al.
AIDS Research and Human Retroviruses|January 3, 2023
Prevalence and Temporal Trends of Autoimmune Diseases in People Living with HIVLuis Ramos-Ruperto, Carmen Busca, Alejandro Díez-Vidal, et al.
The Journal of Infectious Diseases|July 9, 2018
Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1Natalia Stella-Ascariz, Rocio Montejano, Javier Rodriguez-Centeno, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Medical Mycology|December 19, 2017
In vitro activity of isavuconazole against fluconazole-resistant isolates of Histoplasma capsulatumAndrej Spec, Patricia Connolly, Rocio Montejano, et al.
Expert Opinion on Drug Safety|December 5, 2017
A safety evaluation of raltegravir for the treatment of HIVRosa de Miguel, Rocio Montejano, Natalia Stella-Ascariz, et al.
Current HIV/AIDS Reports|January 22, 2018
New Strategies of ARV: the Road to SimplificationRosa de Miguel Buckley, Rocio Montejano, Natalia Stella-Ascariz, et al.
Expert Opinion on Drug Safety|February 9, 2021
Risks and benefits of reducing the number of drugs to treat HIV-1 infectionJulen Cadiñanos, Rocio Montejano, Rosa de Miguel Buckley, et al.
Open Forum Infectious Diseases|March 24, 2016
Long-Term Control of Human Immunodeficiency Virus-1 Replication Despite Extensive Resistance to Current Antiretroviral Regimens: Clonal Analysis of Resistance Mutations in Proviral Deoxyribonucleic AcidNatalia Stella-Ascariz, Rocio Montejano, María Martin-Vicente, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2023
The Current Mismatch Between COVID-19 Clinical Trial Design and the Evolving Profile of Hospitalized Patients: A Retrospective Cohort AnalysisRocio Montejano, Alfredo Soler-Carracedo, Alberto M Borobia, et al.
HIV Medicine|May 6, 2026
Preference for different PrEP formulations: A cross-sectional study in a PrEP cohort in SpainAlfredo Soler-Carracedo, Allison R Webel, Luis Ramos-Ruperto, et al.
Open Forum Infectious Diseases|January 12, 2018
Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus StudySarah L Pett, Ken M Kunisaki, Deborah Wentworth, et al.
AIDS Research and Human Retroviruses|January 3, 2023
Prevalence and Temporal Trends of Autoimmune Diseases in People Living with HIVLuis Ramos-Ruperto, Carmen Busca, Alejandro Díez-Vidal, et al.
The Journal of Infectious Diseases|July 9, 2018
Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1Natalia Stella-Ascariz, Rocio Montejano, Javier Rodriguez-Centeno, et al.
Pageof 2